Intabio Inc.

Aug 11, 2020

Intabio Signs Co-Marketing Agreement with Agilent Technologies Inc. to Support Development of Integrated iCIEF-MS Assay

Jun 16, 2020

Intabio launches Blaze(TM) System to accelerate biotherapeutic development

May 07, 2020

Intabio announces new website and digital marketing strategy to support Blaze(TM) system commercial launch

Mar 11, 2020

Intabio and Protein Metrics Launch Strategic Partnership

Feb 06, 2020

Intabio Closes $18 Million Round in Series B Funding to Build Commercial Team and Launch Blaze(TM) Platform

Jan 07, 2020

Intabio Announces Seminal Publication Describing Blaze(TM) Technology for Comprehensive Biopharmaceutical Product Quality Analysis

Jun 03, 2019

Intabio to Present Groundbreaking Innovation in Therapeutic Antibody Quality Characterization at ASMS Conference

Feb 26, 2019

Rohit Khanna Joins Intabio's Board of Directors

Jan 22, 2019

Intabio to Present Latest Advance in Biopharmaceutical Quality Characterization at WCBP Conference

Aug 15, 2018

Intabio Awarded $2.3 Million SBIR Fast Track Grant to Support Commercial Development of a Novel Microchip-based Solution for Biopharmaceutical Analysis

Jun 13, 2018

Intabio to Collaborate with Bruker on Novel Interface For Bruker's UHR-QTOF Mass Spectrometers

Sep 14, 2017

Intabio Announces $2M Seed Financing